[1] F Barclay Shilliday,et al. Multiple species metabolism of PHA-568487, a selective alpha 7 nicotinic acetylcholine receptor agonist. Drug Metab Lett.2010 Aug;4(3):162-72. PMID:20642449
[2] Zhenying Han,et al. Alpha-7 nicotinic acetylcholine receptor agonist treatment reduces neuroinflammation, oxidative stress, and brain injury in mice with ischemic stroke and bone fracture. J Neurochem.2014 Nov;131(4):498-508. DOI:
10.1111/jnc.12817[3] Dingquan Zou,et al.Activation of Alpha-7 Nicotinic Acetylcholine Receptor Reduces Brain Edema in Mice with Ischemic Stroke and Bone Fracture. Mol Neurobiol.2017 Dec;54(10):8278-8286. DOI:
10.1007/s12035-016-0310-8[4] Lorena Colás, et al. In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia. Glia.2018 Aug;66(8):1611-1624. DOI:
10.1002/glia.23326